The reality of living with advanced macular degeneration requires resilience. Currently, the gold standard for treating the aggressive "wet" form of the disease involves regular injections directly into the eye—a heavy burden for patients to bear. While these treatments are effective at slowing vision loss, they are not a permanent cure. Fortunately, the 3D bioprinting market is paving...
English
French
Spanish
Portuguese
Deutsch
Turkish
Dutch
Italiano
Russian
Romaian
Portuguese (Brazil)
Greek